Bristol-Myers Squibb (BMY) - News Mentions

Sign up to add (BMY) to your portfolio and access more historical data.

10%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Johnson & Johnson
Johnson & Johnson
JNJ		 1 0%
Eli Lilly and Company
Eli Lilly and Company
LLY		 0 0%
Pfizer
Pfizer
PFE		 2 33.3%
Astrazeneca
Astrazeneca
AZN		 2 0%
AbbVie
AbbVie
ABBV		 2 100%
Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential - Bright 2026 Prospects
December 19
Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued
December 19
Jim Cramer on Bristol-Myers Squibb Company (BMY): ‘This Stock Has Been Hot Since The Summer’
December 19
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today
December 19
Jim Cramer on Bristol-Myers Squibb (BMY): Why Schizophrenia Drug Cobenfy Could Change the Game
December 19
Urothelial Cancer Drugs Markets and Competitive Landscape Analysis, 2024-2030, Featuring Profiles of 42 Major Companies, Including AstraZeneca, Bristol-Myers Squibb, Celgene Corporation, and Eli Lilly & Co
December 18
Is Bristol-Myers Squibb Company (BMY) the Best Cash-Rich Dividend Stock to Invest In Now?
December 18
Bristol-Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Jefferies Financial Group
December 17
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
December 17
Brokerages Set Bristol-Myers Squibb (NYSE:BMY) Target Price at $54.29
December 16
Is Bristol-Myers Squibb Company (BMY) the Best Weight Loss Stock to Buy Now According to Hedge Funds?
December 16
Jefferies Upgrades Bristol-Myers Squibb (BMY)
December 16
Wellington Management Group LLP Has $7.77 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
December 16
BMY vs. VRTX: Which Stock Is the Better Value Option?
December 16
Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62
December 14
Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know
December 13

Month over Month

Est. daily news mentions.

Nov 2024 1
Oct 2024 2
Sep 2024 1
Aug 2024 1
Jul 2024 2

How often is Bristol-Myers Squibb mentioned in the news?

Bristol-Myers Squibb was mentioned an estimated 1 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Bristol-Myers Squibb performing compared to its industry peers?

Bristol-Myers Squibb underperforms its industry peers when it comes to News Mentions, ranking in the 17th percentile.

Has there been an increase or decrease in news mentions of Bristol-Myers Squibb in the last month?

Bristol-Myers Squibb's was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Bristol-Myers Squibb?

By monitoring mentions in the news for Bristol-Myers Squibb, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Bristol-Myers Squibb, ultimately improving their investment strategies.

Sign up and get more insights on Bristol-Myers Squibb.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact